A70/23 - Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/ Counterfeit Medical Products. Report by the Director-general. Seventieth World Health Assembly, 2017. (With A70/23 Add.1 - Review of the Member State Mechanism On Substandard/Spurious/Falsely-labelled/ Falsified/Counterfeit Medical Products) (with Appendix 1: Guidance on Developing a National Plan for Preventing, Detecting and Responding to Actions, Activities and Behaviours That Result in Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products. Appendix 2: Available Authentication Technologies for the Prevention and Detection of (Ssffc) Medical Products. Appendix 3: Who Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products: Working Definitions)
(2017; 42 pages) [Arabic] [Chinese] [French] [Russian] [Spanish]

Abstract

Report of the fifth meeting of the member state mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products.

Appendix 1:
Guidance on developing a national plan for preventing, detecting and responding to actions, activities and behaviours that result in substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products.

Appendix 2:
Available authentication technologies for the prevention and detection of (SSFFC) medical products.

Appendix 3:
WHO member state mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products: Working definitions.

Related documents
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019